Solid Tumors
📧 Sign up to get email alerts when something new happens for Solid Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2015-08-21Clinical Trial Update: Safety Study of Pharmacokinetics of XL888 in Adults With Solid Tumors [Phase 1]
Phase 1 safety and pharmacokinetics study of XL888 in adults with solid tumors was terminated.
-
CLINICAL_TRIALS trial_result · 2015-08-19Clinical Trial Update: Global Phase1 Study to Assess the Safety and Tolerability of AZD1208 in Advanced Solid Tumors and Malignant Lymphoma [Phase 1]
Global Phase 1 study to assess the safety and tolerability of AZD1208 in patients with advanced solid tumors and malignant lymphoma; the stu…
-
CLINICAL_TRIALS trial_result · 2015-08-18Clinical Trial Update: A Study of the Drug-Drug Interaction of RO5503781 and Posaconazole, the Relative Bioavailability of New Formulations of RO5503781 and the Food-Effect on the Pharmacokinetics of RO5503781 in Patients With Solid Tumors [Phase 1]
Phase 1 study evaluating drug-drug interaction between RO5503781 and posaconazole, oral formulation bioavailability of RO5503781, and the fo…
-
CLINICAL_TRIALS trial_result · 2015-08-13Clinical Trial Update: An Open-Label Study of YM155 + Docetaxel in Subjects With Advanced Hormone Refractory Prostate Cancer and Other Solid Tumors [Phase 1, Phase 2]
Open-label Phase 1/2 trial evaluating YM155 in combination with docetaxel in advanced hormone-refractory prostate cancer and other solid tum…
-
CLINICAL_TRIALS research · 2015-08-13Clinical Trial Update: Analysis of Data Collected in the European Group for Blood and Marrow Transplantation (EBMT) Registry for Off-Label Transplant Use of Plerixafor
Analysis of EBMT registry data evaluates off-label use of plerixafor in hematopoietic cell transplantation, summarizing indications and obse…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-07-28Clinical Trial Update: Nivestim® (Filgrastim) Tolerance in Patients Treated by Toxic Chemotherapeutic Agents
This clinical trial update reports on the tolerance of Nivestim (filgrastim) in patients treated with highly toxic chemotherapeutic regimens…
-
CLINICAL_TRIALS trial_result · 2015-07-15Clinical Trial Update: Pantoprazole With Doxorubicin for Advanced Cancer Patients With Extension Cohort of Patients With Solid Tumours [Phase 1]
A completed Phase 1 trial assessing pantoprazole in combination with doxorubicin in patients with advanced solid tumors, including an extens…
-
CLINICAL_TRIALS trial_result · 2015-07-02Clinical Trial Update: Tivantinib in Treating Younger Patients With Relapsed or Refractory Solid Tumors [Phase 1]
Phase 1 clinical trial update on tivantinib for pediatric relapsed/refractory solid tumors. The trial has completed.
-
CLINICAL_TRIALS trial_result · 2015-06-30Clinical Trial Update: To Assess the Effect of Itraconazole and Fluconazole on the Pharmacokinetics of Selumetinib in Healthy Male Volunteers [Phase 1]
Phase 1 study evaluating whether itraconazole and fluconazole alter the pharmacokinetics of selumetinib in healthy male volunteers. The tria…
-
CLINICAL_TRIALS trial_result · 2015-06-30Clinical Trial Update: To Assess the Pharmacokinetics, Safety and Tolerability of Selumetinib in Renal Impaired Subjects and Healthy Subjects [Phase 1]
Phase 1 pharmacokinetics and safety study evaluating selumetinib in renal-impaired and healthy subjects has been completed.
-
CLINICAL_TRIALS trial_result · 2015-06-18Clinical Trial Update: Phase I and Pharmacology Study of Camptothecin-20-O-Propionate Hydrate (CZ48) in Patients With Solid Tumors or Lymphoma [Phase 1]
Phase I pharmacology study evaluating camptothecin-20-O-propionate hydrate (CZ48) in patients with advanced solid tumors or lymphomas; the t…
-
CLINICAL_TRIALS trial_result · 2015-06-18Clinical Trial Update: A Combination of Pazopanib and Carboplatin in Advanced Solid Malignancies [Phase 1]
A Phase 1 trial evaluating pazopanib in combination with carboplatin for advanced metastatic solid malignancies; the study was terminated.
-
CLINICAL_TRIALS withdrawal · 2015-06-17Clinical Trial Update: MK0457 (an Aurora Kinase Inhibitor) Study in Patients With Advanced Colorectal Cancer and Other Advanced Solid Tumors (0457-001) [Phase 1]
A Phase 1 study of MK0457, an Aurora kinase inhibitor, in patients with advanced colorectal cancer and other advanced solid tumors was termi…
-
CLINICAL_TRIALS withdrawal · 2015-06-16Clinical Trial Update: Single Dose of Intravenous rhTNF-α and Liposomal Doxorubicin in Patients With Advanced Solid Tumors or Lymphomas [Phase 1]
The Phase 1 trial evaluating a single dose of intravenous recombinant human TNF-α with liposomal doxorubicin in patients with advanced solid…
-
CLINICAL_TRIALS trial_result · 2015-05-28Clinical Trial Update: Safety Study Of Cetuximab Plus Dasatinib (BMS-354825) in Treating Advanced Solid Malignancies [Phase 1]
This clinical trial update notes the completion of a Phase 1 safety study investigating cetuximab plus dasatinib in patients with advanced s…
-
CLINICAL_TRIALS trial_result · 2015-05-20Clinical Trial Update: A Study of NM-3 Administered Orally in Patients With Advanced Solid Tumors. [Phase 1]
This update reports the completion of a Phase 1 study evaluating NM-3, administered orally, in patients with advanced solid tumors.
-
CLINICAL_TRIALS trial_result · 2015-05-01Clinical Trial Update: Study of PI3 Kinase/mTOR Inhibitor BEZ235 Twice Daily for Advanced Solid Tumors [Phase 1]
This update reports the completion of a Phase 1 trial of BEZ235, a dual PI3K/mTOR inhibitor, in patients with advanced solid tumors.
-
CLINICAL_TRIALS trial_result · 2015-04-30Clinical Trial Update: UCN-01 and Prednisone in Treating Patients With Solid Tumors or Lymphoma [Phase 1]
Phase 1 study of UCN-01 with prednisone in adults with lymphoma or solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2015-04-21Clinical Trial Update: Peritumoral Injection of Immature Dendritic Cells to Irradiated Skin Metastases of Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating peritumoral injections of immature dendritic cells into irradiated skin metastases from solid tumors h…
-
CLINICAL_TRIALS trial_result · 2015-04-20Clinical Trial Update: Phase 1 Weekly Dosing of SCH 727965 in Patients With Advanced Cancer (Study P04629AM6) [Phase 1]
Phase 1 update on weekly dosing of SCH 727965 in patients with advanced cancer, including solid tumors, non-Hodgkin lymphoma, multiple myelo…
-
CLINICAL_TRIALS trial_result · 2015-04-13Clinical Trial Update: Open Label, Dose Escalation Trial of Oral Eg5 Kinesin-spindle Inhibitor 4SC-205 in Patients With Advanced Malignancies [Phase 1]
Open-label Phase 1 dose-escalation study of 4SC-205, an Eg5 kinesin-spindle inhibitor, in patients with advanced solid tumors and malignant …
-
CLINICAL_TRIALS trial_result · 2015-03-25Clinical Trial Update: Laboratory-Treated Autologous Lymphocytes, Aldesleukin, and Sargramostim (GM-CSF) in Treating Advanced Solid Tumors [Phase 1]
This Phase 1 trial evaluated laboratory-treated autologous lymphocytes with aldesleukin and sargramostim (GM-CSF) for advanced solid tumors;…
-
CLINICAL_TRIALS research · 2015-03-24Clinical Trial Update: A Phase Ia, Dose Escalation Study of Humanized Anti-VEGF Monoclonal Antibody (Sevacizumab) Injection in Patients With Advanced or Metastatic Solid Tumors [Phase 1]
This entry describes a Phase Ia dose-escalation study of Sevacizumab, a humanized anti-VEGF monoclonal antibody, in patients with advanced o…
-
CLINICAL_TRIALS trial_result · 2015-03-17Clinical Trial Update: Nesvacumab (REGN910/ SAR307746) and Aflibercept ("Ziv-aflibercept" in the U.S.) in Patients With Advanced Solid Malignancies [Phase 1]
This Phase 1 study evaluates Nesvacumab (REGN910/SAR307746) in combination with aflibercept (Ziv-aflibercept) in patients with advanced soli…
-
CLINICAL_TRIALS withdrawal · 2015-02-16Clinical Trial Update: Ph Ib/BGJ398/Cervix and Other Solid Tumors [Phase 1]
A Phase Ib trial of BGJ398 in cervical cancer and other solid tumors was withdrawn.